Striatal Interneuron Vulnerability In Huntington'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
The striatum contains diverse interneuron populations that are differentially affected in Huntington's disease (HD). Understanding interneuron vulnerability provides insights into circuit dysfunction and therapeutic opportunities.
- Morphology: Large aspiny neurons
- Synaptic Targets: Perisomatic inhibition of MSNs
- Function: Critical for movement initiation
- Firing Pattern: Fast-spiking
- Morphology: Large aspiny neurons (TONICs)
- Markers: ChAT, vesicular acetylcholine transporter
- Function: Modulate MSN excitability
- Firing Pattern: Tonically active (TAN)
- Morphology: Medium aspiny
- Markers: SST, NPY, NOS
- Function: Dendritic inhibition
- Firing Pattern: Late-spiking
- Types: Parvalbumin, calretinin, calbindin
- Function: Feedforward and feedback inhibition
- PV Interneurons: Significant loss in HD
- Cholinergic Interneurons: Progressive degeneration
- SST/NPY Neurons: Reduced numbers
- Calretinin Interneurons: More resilient
- Some GABAergic subtypes
- Mutant huntingtin (mHTT) aggregation
- Transcriptional dysregulation
- Mitochondrial dysfunction
- Altered calcium handling
- Impaired autophagy
- Loss of inhibition on MSNs
- Disrupted corticostriatal integration
- Altered thalamic input
- Network hypersynchrony
- CREB dysfunction: Altered gene expression
- BDNF signaling: Reduced trophic support
- Oxidative stress: Increased ROS
- Neuroinflammation: Glial contributions
- Chorea: Involuntary movements
- Dystonia: Abnormal postures
- Bradykinesia: Slowed movement
- Impaired gait: Balance deficits
- Executive dysfunction: Planning deficits
- Working memory: Information handling
- Behavioral changes: Personality alterations
- GABA agonists: Enhance inhibition
- Cholinergic modulation: Restore signaling
- PV restoration: Cell-based therapies
- HTT lowering: Reduce mHTT in interneurons
- Neurotrophic factors: Support interneuron survival
The study of Striatal Interneuron Vulnerability In Huntington'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] DOI:10.1093/brain/awz369 - Striatal interneurons in HD
[2] DOI:10.1002/j.1460-2075.2012.tbt - mHTT effects on interneurons
[3] DOI:10.1038/s41582-019-0238-5 - Circuit dysfunction in HD